The role of oclacitinib in the management of ischaemic dermatopathy in four dogs.

Britt J Levy Keith E Linder Thierry Olivry

Published in: Veterinary dermatology (2019)

Oclacitinib was a useful immunosuppressive adjuvant to oral glucocorticoids for the treatment of refractory or severe cases of ischaemic dermatopathy in these four dogs. Such observation warrants further studies of the safety, efficacy and mechanism of action of oclacitinib as an immunosuppressant.

Keyphrases

early stage
early onset
replacement therapy